31
Views
11
CrossRef citations to date
0
Altmetric
Reports

Immunomodulatory effect of β‐carotene on T lymphocyte subsets in patients with resected colonic polyps and cancer

, , , , , & show all
Pages 140-145 | Received 16 Jan 1997, Accepted 28 Apr 1997, Published online: 04 Aug 2009

References

  • Fontham , ET . 1990 . “Protective dietary factors and lung cancer” . Int J Epidemiol , 19 : S32 – S42 .
  • Singh , VN and Gaby , SK . 1991 . “Premalignant lesions: role of antioxidant vitamins and β‐carotene in risk reduction and prevention of malignant transformation” . Am J Clin Nutr , 53 : 386S – 390S .
  • Wald , NJ , Thompson , SG , Densem , JW , Boreham , J and Bailey , A . 1988 . “Serum β‐carotene and subsequent risk of cancer: result from the BUPA study” . Br J Cancer , 57 : 428 – 433 .
  • Ziegler , RG . 1989 . “A review of epidemiological evidence that carotenoids reduce the risk of cancer” . J Nutr , 119 : 116 – 122 .
  • Stahelin , HB , Rosel , F , Buess , E and Brubacher , G . 1984 . “Cancer, vitamins, and plasma lipids: prospective basal study” . JNCI , 73 : 1463 – 1468 .
  • Gey , F and Brubacher , GB . 1987 . “Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer” . Am J Clin Nutr , 45 : 1368 – 1377 .
  • Kneller , RW , Guo , W‐D , Hsing , AW , Chen , J‐S Blot , WJ . 1992 . “Risk factors for stomach cancer in sixty‐five Chinese counties” . Cancer Epidemiol Biomarkers Prev , 1 : 113 – 118 .
  • Alpha‐Tocopherol, Beta‐Carotene Cancer Prevention Study Group . 1994 . “The effect of Vitamin E and β‐carotene on the incidence of lung cancer and other cancer in male smokers” . N Engl J Med , 330 : 1029 – 1035 .
  • Greenberg , ER , Baron , JA , Tosteson , TD , Freeman , DH Beck , GJ . 1994 . “A clinical trial of antioxidant vitamins to prevent colorectal adenoma” . N Engl J Med , 331 : 141 – 147 .
  • Omenn , GS , Goodman , GE , Thornquist , MD , Balmes , J Cullen , MR . 1996 . “Risk factors for lung cancer and for intervention effect in CARET, the β‐carotene and retinol efficacy trial” . JNCI , 88 : 1550 – 1559 .
  • Burton , GW and Ingold , KV . 1984 . “β‐Carotene: an unusual type of lipid antioxidant” . Science , 224 : 569 – 573 .
  • Burton , GW . 1989 . “Antioxidant actions of carotenoids” . J Nutr , 19 : 109 – 111 .
  • Bendich , A . 1988 . “A role for carotenoids in immune function” . Clin Nutr , 7 : 113 – 117 .
  • Watson , RR , Jackson , JC , Leigh , S , Hicks , MJ and Alberts , DS . 1986 . “Cellular immune functions of adults treated with a long‐term low dose of 13‐cis retinoic acid” . J Leukocyte Biol , 116 : 2254 – 2262 .
  • Peto , R , Doll , R , Buckley , JD and Sporn , MB . 1981 . “Can dietary β‐carotene materially reduce human cancer rates?” . Nature , 290 : 201 – 208 .
  • Krinsky , NI and Deneke , S . 1982 . “Interaction of oxygen and oxy‐radicals with carotenoids” . JNCI , 69 : 205 – 210 .
  • Hennekens , CH , Mayrent , SL and Willett , W . 1986 . “Vitamin A, carotenoids, and retinoids” . Cancer , 58 : 1837 – 1841 .
  • Zhang , LX , Cooney , RV and Bertram , JS . 1991 . “Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/ 10T1/2 cells: relationship to their cancer chemoprevention action” . Carcinogenesis , 12 : 2109 – 2114 .
  • Stacewicz‐Sapuntzakis , M , Bowen , PE , Kikendall , JW and Burgess , M . 1987 . “Simultaneous determination of serum retinol and various carotenoids: their distribution in middle‐aged men and women” . J Micronutr Anal , 3 : 27 – 45 .
  • Tang , G , Shiau , A , Russell , RM and Mobarhan , S . 1995 . “Serum retinoic acid levels in patients with resected benign and malignant colonic neoplasias on β‐carotene supplementation” . Nutr Cancer , 23 : 291 – 298 .
  • Becton‐Dickinson . 1989 . “Direct immunofluorescence staining of cell surfaces” . In Becton‐Dickinson Procedures Sourcebook , Sunnyvale, CA : Becton‐Dickinson Immunocytometry Systems . sect 2.4.
  • Mobarhan , S , Shiau , A , Grande , A , Srinivas , K Stacewicz‐Sapuntzakis , M . 1994 . “β‐Carotene supplementation results in an increased serum and colonic mucosal concentration of β‐carotene and a decrease in α‐tocopherol concentration in patients with colonic neoplasia” . Cancer Epidemiol Biomarkers Prev , 3 : 501 – 505 .
  • Frommel , TO , Mobarhan , S , Doria , M , Halline , AG Luk , GD . 1995 . “Effect of β‐carotene supplementation on indices of colonic cell proliferation” . JNCI , 87 : 1781 – 1787 .
  • Costantino , JP , Kuller , LH , Begg , L , Redmond , CK and Bates , MW . 1988 . “Serum level changes after administration of a pharmacologic dose of β‐carotene” . Am J Clin Nutr , 48 : 1277 – 1283 .
  • Albanes , D , Virtamo , J , Rautalahti , M , Haukka , J Palmgren , J . 1992 . “Serum β‐carotene before and after β‐carotene supplementation” . Eur J Clin Nutr , 46 : 15 – 24 .
  • Alexander , M , Newmark , H and Miller , RG . 1985 . “Oral β‐carotene can increase the number of OKT4+ cells in human blood” . Immunol Lett , 9 : 221 – 224 .
  • Watson , RR , Prabhala , RH , Plezia , PM and Alberts , DS . 1991 . “Effect of β‐carotene on lymphocyte subpopulation in elderly humans: evidence for a dose‐response relationship” . Am J Clin Nutr , 53 : 90 – 94 .
  • Ringer , TV , DeLoof , MJ , Winterrowd , GE , Francom , SF Gaylor , SK . 1991 . “β‐Carotene's effects on serum lipoproteins and immunologic indices in humans” . Am J Clin Nutr , 53 : 688 – 694 .
  • Van Poppel , G , Spanhaak , S and Ockhuizen , T . 1993 . “Effect of β‐carotene on immunological indexes in healthy male smokers” . Am J Clin Nutr , 57 : 402 – 407 .
  • Murata , T , Hiroshi , T , Morinobu , T , Manago , M Takenaka , H . 1994 . “Effect of long‐term administration of β‐carotene on lymphocyte subsets in humans” . Am J Clin Nutr , 60 : 597 – 602 .
  • Coodley , GO , Nelson , HD , Loveless , MO and Folk , C . 1993 . “β‐Carotene in HIV infection” . J Acquired Immune Deficiency Syndrome , 6 : 272 – 276 .
  • Prabhala , RH , Braune , LM , Garewal , HS and Watson , RR . 1993 . “Influence of β‐carotene on immune function” . Ann NY Acad Sci , 691 : 262 – 263 .
  • Stewart , TH , Hollinshead , AC and Raman , S . 1991 . “Tumour dormancy: initiation, maintenance and termination in animals and humans” . Can J Sura , 34 : 321 – 325 .
  • Walker , TM , Yurochko , AD , Burger , CJ and Elgert , KD . 1992 . “Cytokines and suppressor macrophages cause tumor‐bearing host CDI+T cells to suppress recognition of allogenic and syngeneic MHC class II molecules” . J Leukocyte Biol , 52 : 661 – 669 .
  • Waldmann , TA . 1989 . “Multichain IL‐2 receptor: a target for immunotherapy in lymphoma” . JNCI , 81 : 914 – 923 .
  • Waldmann , TA . 1986 . “The structure, function, and expression of IL2 receptor on normal and malignant lymphocytes” . Science , 232 : 727 – 732 .
  • Robb , RJ , Munck , A and Smith , KA . 1981 . “T cell growth factor receptors: quantitation, specificity, and biological relevance” . J Exp Med , 154 : 1455 – 1474 .
  • Trinchieri , G , Matsumoto‐Kobayashi , M , Clark , SC , Seehra , J London , L . 1984 . “Response of resting human peripheral blood natural killer cells to interleukin 2” . J Exp Med , 160 : 1147 – 1159 .
  • McGuire , KL , Yang , JA and Rothenburg , EV . 1988 . “Influence of activating stimulus on functional phenotype: interleukin‐2 mRNA accumulation differently induced by ionophore and receptor ligands in subsets of murine T cells” . Proc Natl Acad Sci USA , 85 : 6503 – 6507 .
  • Alex‐Martinez , JE , Alvarez‐Mon , M , Merino , F , Bonilla , F Martinez , C . 1988 . “Decreased TcR‐CD3+ T‐cell numbers in healthy, aged humans. Evidence that T‐cell defects are masked by a reciprocal increase of TcR‐CD3‐CD2+ natural killer cells” . Eur J Immunol , 18 : 1827 – 1830 .
  • Teodorczyk‐Injeyan , JA , Sparkes , BG , Mills , GB , Peters , WJ Falk , RE . 1986 . “Impairment of T‐cell activation in bum patients: a possible mechanism of thermal injury‐induced immunosuppression” . Clin Exp Immunol , 65 : 570 – 581 .
  • Kay , NE and Kaplan , ME . 1986 . “Defective T‐cell responsiveness in chronic lymphocytic leukemia: analysis of activation events” . Blood , 67 : 578 – 581 .
  • Merluzzi , VJ , Welk , K , Savage , DM , Last‐Barney , K Mertelsmann , R . 1983 . “Expansion of cyclophosphamide‐resistant cytotoxic precursors in vitro and in vivo by purified human interleukin 2” . J Immunol , 131 : 806 – 809 .
  • Lissoni , P , Barni , S , Rovelli , F , Rescaldani , R Biondi , A . 1990 . “Correlation of serum interleukin‐2 levels, soluble interleukin‐2 receptors and ? lymphocyte subsets in cancer patients” . Tumori , 76 : 14 – 17 .
  • Rosenberg , SA , Lotze , MT , Yang , JC , Aebersold , PM Linehan , WM . 1989 . “Experience with the use of high‐dose interleukin‐2 in the treatment of 652 cancer patients” . Ann Surg , 210 : 474 – 485 .
  • Yasumura , S , Lin , WC , Weidmann , E , Hebda , P and Whiteside , TL . 1994 . “Expression of interleukin‐2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin‐2” . Int J Cancer , 59 : 225 – 234 .
  • Maiani , G , Pappalardo , G , Ferro‐Luzzi , A , Raguzzini , A Azzini , E . 1995 . “Accumulation of β‐carotene in normal colorectal mucosa and colonic neoplastic lesions in humans” . Nutr Cancer , 24 : 23 – 31 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.